Affiliation:
1. National Food and Drug Surveillance Institute (INVIMA), Carrera 10 # 64, 28 Bogota, Colombia
Abstract
Background:
The Colombian National Food and Drug Surveillance Institute (INVIMA) is
responsible for monitoring the safety and efficacy of medicines circulating the Colombian market.
Discussion:
This article summarizes the three key strategies the institution has implemented to
strengthen the National Pharmacovigilance Program: improving the interaction and working
relationship with regional health authorities, expanding the National Pharmacovigilance Network and
implementing the electronic submission of adverse events.
Conclusion:
The number of adverse events reported in Colombia increased from 5,447 in 2013 to 95,658
in 2017, reaching a population-based reporting ratio within international standards (563 in 2016).
Publisher
Bentham Science Publishers Ltd.
Subject
Pharmacology (medical),Pharmacology,Toxicology
Reference5 articles.
1. . World Health Organization. Reporting and learning system for medication errors: The role of pharmacovigilance centres. WHO Press [Internet] 2014; 96. Available from:
2. . World Health Organization. Pharmacovigilance: Guarantee of safety in the use of medicines. Perspectives policies WHO on Medicam 2004; 1-6. Available from:
3. . INVIMA. Resolution number 2004009455 of 2004. Colombia;
2004. Available from:
4. . Ministry of Social Protection. Decree 2200 of 2005. Available from:
5. Tanti A, Micallef B, Serracino-Inglott A, Borg JJ. A review of the national pharmacovigilance system in malta - Implementing and operating a pharmacovigilance management system.